The Journal of Ophthalmology, published by HINDAWI LTD, is an esteemed open-access journal that has been disseminating significant research in the field of ophthalmology since 2009. With an ISSN of 2090-004X and an E-ISSN of 2090-0058, this journal facilitates global access to cutting-edge studies, making it an essential resource for researchers, clinicians, and students alike. Ranked in the Q2 category of ophthalmology for 2023, the journal holds a commendable position with a Scopus rank of #37 out of 137 in its field, placing it in the 73rd percentile. The journal encompasses a variety of topics such as clinical advancements, surgical techniques, and innovative technologies in eye care, aiming to advance scientific knowledge and clinical practice in ophthalmology. By providing a platform for both novel research and comprehensive reviews, the Journal of Ophthalmology is instrumental in fostering collaboration and scholarly communication within the global eye health community, and its commitment to open access ensures that impactful research reaches a wide audience without barriers.

Investigative Ophthalmology & Visual Science (IOVS) is a leading academic journal published by the Association for Research in Vision and Ophthalmology, dedicated to advancing the field of ophthalmology and visual science. With an impressive impact factor and ranking in the Q1 category for both Ophthalmology and Sensory Systems, IOVS is well-respected for disseminating cutting-edge research and innovative discoveries. Established in 1977, this Open Access journal allows for broad accessibility to pioneering studies, fostering collaboration among researchers, clinicians, and students. The journal has consistently maintained high visibility in the academic community, evidenced by its robust rankings in Scopus, including Rank #16 in Ophthalmology. As it continues to pave the way for future developments in the understanding and treatment of ocular diseases, IOVS serves as an invaluable resource for those immersed in the complex field of visual science.

JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, published by Mary Ann Liebert, Inc, stands at the forefront of research in the realms of ophthalmology and pharmacology. Established in 1985 and converging until 2024, this esteemed journal is dedicated to advancing the understanding of ocular pharmacology, drug therapies, and therapeutic approaches in the treatment of eye diseases. With an impressive impact factor and categorized in the Q2 quartile for both Ophthalmology and Medical Pharmacology, it showcases pivotal research in the field, reflecting its rank of #31 among 137 in Ophthalmology and #109 among 272 in Medical Pharmacology per Scopus metrics. Although it follows a subscription-based model, the journal provides critical insights and empirical studies that foster innovation and collaboration for researchers, professionals, and students alike in the pursuit of improving ocular health.

Klinische Monatshefte für Augenheilkunde is a distinguished peer-reviewed journal published by Georg Thieme Verlag KG, dedicated to advancing knowledge in the field of ophthalmology and general medicine. With an ISSN of 0023-2165 and an E-ISSN of 1439-3999, this journal has been a reputable platform for researchers and clinicians since its inception in 1963, continuing its impactful contributions through to 2024. Recognized in the Q3 quartile for both Medicine (miscellaneous) and Ophthalmology, this journal serves as a vital resource for those involved in ocular health, offering insights into clinical practices, recent advancements, and essential research findings. Despite its traditional publishing model, the journal retains a significant role in the academic community, as evidenced by its current Scopus ranking of #90/137 in the field of Ophthalmology. It is an essential read for professionals and students aiming to stay at the forefront of ophthalmic research and clinical innovations.

The British Journal of Ophthalmology, published by the BMJ Publishing Group, stands as a leading peer-reviewed journal in the field of ocular sciences, with a distinctive focus on advancing the understanding of vision and its impairment. With a rich history dating back to 1941, this journal serves as an essential platform for researchers, professionals, and students in ophthalmology and related disciplines. It prominently ranks in the Q1 quartile for Ophthalmology and Cellular and Molecular Neuroscience in 2023, reflecting its esteemed reputation in the scientific community. The journal boasts impressive Scopus rankings, including Rank #6 in Medicine - Ophthalmology, showcasing its influential contributions to the field. Although it does not offer open access, the journal is committed to disseminating high-quality research that informs clinical practices and enriches the understanding of sensory systems. Submissions are encouraged from all areas of ophthalmology, including clinical studies, innovative research, and systemic reviews. Join the vibrant academic dialogue by engaging with the cutting-edge findings published in the British Journal of Ophthalmology, which aims to bridge the gap between research and clinical application.

Augenheilkunde Up2date is a pivotal journal in the field of ophthalmology, published by GEORG THIEME VERLAG KG, a renowned publisher known for its commitment to advancing medical knowledge. With its ISSN 1616-9719 and E-ISSN 1616-9735, this journal serves as a vital resource for researchers, professionals, and students interested in the latest developments and nuanced discussions in eye health. Although not available as open access, its curated content offers significant insights into contemporary research, clinical practices, and emerging trends in ophthalmology, thus promoting the continuous professional development of its readers. There is an emphasis on providing comprehensive reviews that encapsulate the pertinent advancements in the field, making it an essential publication for those aiming to enhance their expertise in eye care and vision science.

CURRENT EYE RESEARCH is a prestigious academic journal published by Taylor & Francis Inc, focusing on advancing the field of ophthalmology and its intersection with cellular and molecular neuroscience. Since its inception in 1981, this journal has provided a vital platform for original research, reviews, and technical notes, presenting a wealth of knowledge to practitioners and researchers alike. With an impressive 2023 impact factor reflected in its ranking of Q2 in Ophthalmology and Q2 in Sensory Systems, and a Q3 ranking in Cellular and Molecular Neuroscience, CURRENT EYE RESEARCH plays a crucial role in fostering interdisciplinary collaboration and innovation. The journal is indexed in Scopus, where it holds strong positions in both the Medicine and Neuroscience categories, enhancing its visibility and reach. Researchers and professionals in these fields can access cutting-edge findings and contribute to the ongoing discourse surrounding eye health, making it an essential resource for anyone invested in advancing knowledge and treatment in ophthalmic science.

PROGRESS IN RETINAL AND EYE RESEARCH, published by PERGAMON-ELSEVIER SCIENCE LTD, is a premier journal dedicated to the advancement of knowledge in the fields of ophthalmology and sensory systems. With an impressive impact factor and a Q1 category ranking in both Ophthalmology and Sensory Systems as of 2023, this journal exemplifies excellence in research dissemination. Given its stature, it ranks #1 out of 137 in Ophthalmology and #1 out of 42 in Neuroscience - Sensory Systems, placing it within the top percentile of scientific publications in these domains. The journal has been actively contributing to the field since its inception in 1994 and continues to be a vital resource for researchers, clinicians, and students seeking the latest insights and breakthroughs in the understanding of retinal diseases and eye health. While it maintains a traditional subscription model, the journal remains committed to publishing high-quality, peer-reviewed articles that drive forward the frontiers of eye research and therapeutic innovation. With its strong scientific rigor and a vast array of articles, PROGRESS IN RETINAL AND EYE RESEARCH is indispensable for anyone invested in the study of visual sciences.

Eye & Contact Lens-Science and Clinical Practice, published by Lippincott Williams & Wilkins, stands as a premier journal in the fields of ophthalmology and contact lens research. With an ISSN of 1542-2321 and an E-ISSN of 1542-233X, this journal serves as a vital resource for researchers, clinicians, and students dedicated to the study and application of eye care practices. Maintaining a distinguished impact factor within the Q2 category of Medicine and Ophthalmology as of 2023, it ranks impressively at #33 among 137 journals, placing it in the top 76th percentile according to Scopus metrics. Since its inception in 1986, Eye & Contact Lens has consistently delivered cutting-edge research and clinical insights, facilitating advancements in therapeutic techniques for contact lens wear and ocular health. Though not an Open Access journal, it remains accessible through institutional subscriptions, ensuring that essential findings are shared among professionals in the field. The objective of the journal is to present high-quality, peer-reviewed articles that advance the science and practice of eye care, making it an indispensable tool for those seeking to enhance their knowledge and contribute to this dynamic discipline.

CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY is a leading peer-reviewed journal published by Wiley, renowned for its commitment to advancing the field of ophthalmology. With an impressive impact factor reflecting its high-quality research contributions, this journal is ranked in the Q1 category both in Medicine (miscellaneous) and Ophthalmology, signifying its crucial role in shaping contemporary ophthalmic research. It boasts a remarkable position in the Scopus Ranks, standing at Rank #13 out of 137 in the field of Medicine and Ophthalmology, placing it within the 90th percentile among its peers. Having been in circulation since 1979, this journal encompasses a broad scope of topics that aim to disseminate groundbreaking findings and stimulate dialogue among researchers, clinicians, and students alike. It is easily accessible to a global audience, embodying the principles of open access, making valuable research available to all. For anyone seeking to stay at the forefront of ophthalmology, CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY is an indispensable resource that fosters knowledge and innovation in the ever-evolving landscape of eye care.